Patent Yard Sign in
Canadian application, no grantCanada

Novel compounds derived from .alpha.-d-xylose, preparation method and therapeutic use

CA 2335799 A1 · Owner: Edgar, Alan Dunlap · Inventors: Edgar, Alan Dunlap; Barberousse, Veronique; Legendre, Christiane

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention concerns .alpha.-D-xylose compounds as novel industrial , products, corresponding to formula (I) wherein: X and Y represent independently of each other, an oxygen atom or a sulphur atom; R1 represents a CN, CF3, SO2CH3 group; and R represents a hydrogen atom or an aliphatic acyl group comprising 2 to 5 carbon atoms. The invention also concerns the preparation method and the therapeutic use of said compounds of formula (I).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 11, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 11, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 11, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 11, 1999
GrantedNo grant recorded
Term endedJune 11, 2019
Patent numberCA 2335799 A1
Classification (IPC)C07H15/20 +1 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedJune 11, 1999Term endedJune 11, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.